Literature DB >> 10882478

Genetically perpetuated human neural stem cells engraft and differentiate into the adult mammalian brain.

F J Rubio1, C Bueno, A Villa, B Navarro, A Martínez-Serrano.   

Abstract

Human neural stem cells (HNSCs) may serve as a cellular vehicle for molecular therapies as well as for cell replacement in the human CNS. The survival, integration, and differentiation of HNSC.100, a multipotent cell line of HNSCs (A. Villa et al. (2000), Exp. Neurol. 161, 67-84), conditionally perpetuated by genetic and epigenetic means, was investigated after transplantation to the striatum and substantia nigra of the adult, intact rat brain. These are two key regions in the mammalian brain involved in the control of voluntary movement and motor coordination, among other functions. Soon after transplantation (1 week), the cells had already integrated in a nondisruptive manner into the surrounding tissue and migrated out of the implantation site to different distances depending on graft location (in the range of 0.5-2.5 mm). Cell migration was markedly more extensive in the striatum, where the cells colonized the whole extent of the caudate-putamen, than in the substantia nigra region. The engrafted cells completely downregulated the stem cell marker nestin and, due to their multipotential nature, differentiated and expressed mature neural markers. As expected from cells grafted into nonneurogenic regions of the intact brain, the majority of differentiated cells expressed GFAP (astroglia), but expression of other markers, like GalC (oligodendroglia) and MAP2, beta-tubulin III, NeuN, and NSE (for mature neurons) could also be detected. These results demonstrate that genetically perpetuated HNSCs, once transplanted, find residence in the host brain, where they differentiate, generating mature neural cells in the host, chimeric, adult mammalian brain. HNSCs cell lines may be a highly useful model for the development of humanized systems for cell replacement and/or gene transfer to the CNS, which will likely be strong candidates for future therapeutic application in human neurodegenerative conditions. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882478     DOI: 10.1006/mcne.2000.0854

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  16 in total

1.  Orthotopic transplantation of immortalized mesencephalic progenitors (CSM14.1 cells) into the substantia nigra of hemiparkinsonian rats induces neuronal differentiation and motoric improvement.

Authors:  Stefan Jean-Pierre Haas; Stanislav Petrov; Golo Kronenberg; Oliver Schmitt; Andreas Wree
Journal:  J Anat       Date:  2007-11-23       Impact factor: 2.610

2.  Effects of cytomegalovirus infection in human neural precursor cells depend on their differentiation state.

Authors:  H M González-Sánchez; A Monsiváis-Urenda; C A Salazar-Aldrete; A Hernández-Salinas; D E Noyola; M E Jiménez-Capdeville; A Martínez-Serrano; C G Castillo
Journal:  J Neurovirol       Date:  2015-04-08       Impact factor: 2.643

3.  Survival, differentiation, and neuroprotective mechanisms of human stem cells complexed with neurotrophin-3-releasing pharmacologically active microcarriers in an ex vivo model of Parkinson's disease.

Authors:  Nicolas Daviaud; Elisa Garbayo; Laurence Sindji; Alberto Martínez-Serrano; Paul C Schiller; Claudia N Montero-Menei
Journal:  Stem Cells Transl Med       Date:  2015-04-29       Impact factor: 6.940

Review 4.  Mammalian neural stem-cell renewal: nature versus nurture.

Authors:  Yvan Arsenijevic
Journal:  Mol Neurobiol       Date:  2003-02       Impact factor: 5.590

5.  Modeling HIV Latency in Astrocytes with the Human Neural Progenitor Cell Line HNSC.100.

Authors:  Amelie Bauer; Ruth Brack-Werner
Journal:  Methods Mol Biol       Date:  2022

6.  Transcription of genes encoding synaptic vesicle proteins in human neural stem cells: chromatin accessibility, histone methylation pattern, and the essential role of rest.

Authors:  Myriam Ekici; Mathias Hohl; Frans Schuit; Alberto Martínez-Serrano; Gerald Thiel
Journal:  J Biol Chem       Date:  2008-01-30       Impact factor: 5.157

7.  Bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model.

Authors:  Khalid Shah; Shawn Hingtgen; Randa Kasmieh; Jose Luiz Figueiredo; Elisa Garcia-Garcia; Alberto Martinez-Serrano; Xandra Breakefield; Ralph Weissleder
Journal:  J Neurosci       Date:  2008-04-23       Impact factor: 6.167

8.  In vitro and in vivo enhanced generation of human A9 dopamine neurons from neural stem cells by Bcl-XL.

Authors:  Elise T Courtois; Claudia G Castillo; Emma G Seiz; Milagros Ramos; Carlos Bueno; Isabel Liste; Alberto Martínez-Serrano
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

9.  Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease.

Authors:  Verena Johann; Johannes Schiefer; Christian Sass; Jörg Mey; Gary Brook; Alexander Krüttgen; Christiane Schlangen; Christian Bernreuther; Melitta Schachner; Marcel Dihné; Christoph M Kosinski
Journal:  Exp Brain Res       Date:  2006-09-30       Impact factor: 2.064

10.  Clonal human fetal ventral mesencephalic dopaminergic neuron precursors for cell therapy research.

Authors:  Tania Ramos-Moreno; Javier G Lendínez; María José Pino-Barrio; Araceli Del Arco; Alberto Martínez-Serrano
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.